Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations
Sergio Giralt(Memorial Sloan Kettering Cancer Center), Steven M. Devine(National Marrow Donor Program), John M. McCarty(Virginia Commonwealth University), Paul Shaughnessy(CHRISTUS Transplant Institute), Edward A. Copelan(Carolinas Healthcare System), Damiano Rondelli(University of Illinois Chicago), Helen Leather(University of Florida), Edward L. Snyder(Yale University), Chitra Hosing(The University of Texas MD Anderson Cancer Center), John F. DiPersio(Washington University in St. Louis), Robert J. Soiffer(Dana-Farber Cancer Institute), Amy Pazzalia(University of Florida), Richard T. Maziarz(Oregon Health & Science University), Jeffrey Schriber, Finn Bo Petersen(Intermountain Healthcare), Robert S. Negrin(Stanford Blood Center), William Bensinger(Fred Hutch Cancer Center), Luciano J. Costa(Université Paris Cité)
Cited by 402
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k